No abstract

No abstract

No abstract

The fouling behavior of carbon nanotube (CNT) membranes is investigated for large protein biomolecules and a wide variety of small molecules. The CNT membranes are largely fouling resistant, even to untreated river water, due to size exclusion and an inert graphitic core that supports fast fluid flow. However, it is found that bovine serum albumin (BSA) and naphthalene significantly foul membranes due to solution coagulation and π–π stacking, respectively. Small single‐walled (SW) CNTs (<1.5 nm i.d.) are difficult to foul with BSA when precipitation is prevented, showing that size exclusion at SWCNT tips can prevent fouling. Electrochemical oxidation, bubble generation and ionic pumping are shown to recover membrane performance. Electrochemical oxidation at greater than +1.4 V is seen to oxidize CNTs as well as biofoulants, but H2 bubble generation at –2 V lifts foulants without damage to the membrane allowing for repeated cycles. Ionic pumping using large cations is seen to remove small molecule foulants adsorbed to the CNT core. The relatively narrow class of foulants and three complementary methods of membrane defouling make the CNT membrane platform a potentially robust system for a wide variety of chemical separations and environmental water treatments.

Gold-gold sulfide nanoparticles (GGS-NPs) fabricated from chloroauric acid and sodium thiosulfate show unique near infrared (NIR) absorption that renders them as a promising candidate for photothermal cancer therapy. To improve targeting efficiency, we developed a versatile method to allow ordered immunoconjugation of antibodies on the surfaces of these nanoparticles via a PEGylated recombinant Protein G (ProG). The PEGylated ProG was prepared with orthopyridyldisulfide-polyethylene glycol-succinimidyl valerate, average MW 2000 (OPSS-PEG-SVA), to first allow the self-assembly of ProG on the nanoparticles, subsequently antibodies were added to this construct to enable active targeting. The bioconjugated GGS-NPs were characterized by TEM, NIR-spectra, dynamic light scattering and modified immunoassay. In in vitro studies, the ProG-conjugated GGS-NPs with bound mouse anti c-erbB-2 (HER-2) immunoglobulin G (IgG) successfully targeted the HER-2 overexpressing breast cancer cell, SK-BR-3. Extensive cell death was observed for the targeted SK-BR-3 line at a low laser power of 540 J (3 W cm(-2) for 3 min) while the control breast cancer cell (low expressing HER-2), HTB-22 survived. Using PEGylated ProG as a cofactor for immobilization of antibodies offers a promising strategy to functionalize various IgGs on nanoparticles for engineering their biomedical applications in cancer therapeutics.

Nano-scale particles sized 10–400 nm administered systemically preferentially extravasate from tumor vasculature due to the enhanced permeability and retention effect. Therapeutic success remains elusive, however, because of inhomogeneous particle distribution within tumor tissue. Insufficient tumor vascularization limits particle transport and also results in avascular hypoxic regions with non-proliferating cells, which can regenerate tissue after nanoparticle-delivered cytotoxicity or thermal ablation. Nanoparticle surface modifications provide for increasing tumor targeting and uptake while decreasing immunogenicity and toxicity. Herein, we created novel two layer gold-nanoshell particles coated with alkanethiol and phosphatidylcholine, and three layer nanoshells additionally coated with high-density-lipoprotein. We hypothesize that these particles have enhanced penetration into 3-dimensional cell cultures modeling avascular tissue when compared to standard poly(ethylene glycol) (PEG)-coated nanoshells. Particle uptake and distribution in liver, lung, and pancreatic tumor cell cultures were evaluated using silver-enhancement staining and hyperspectral imaging with dark field microscopy. Two layer nanoshells exhibited significantly higher uptake compared to PEGylated nanoshells. This multilayer formulation may help overcome transport barriers presented by tumor vasculature, and could be further investigated in vivo as a platform for targeted cancer therapies.

No abstract

No abstract